Carregant...
Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease
No treatment until now has directly targeted the mechanisms responsible for the development and growth of cysts in autosomal dominant polycystic kidney disease (ADPKD). Strong rationale and preclinical studies using in vitro and in vivo models justified the launching of two large phase 3 clinical tr...
Guardat en:
| Publicat a: | Nephrol Dial Transplant |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657439/ https://ncbi.nlm.nih.gov/pubmed/30312438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy297 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|